(Q40421604)
Statements
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992) (English)
C Theodore
I Skoneczna
I Bodrogi
J M Kerst
L Collette
K Ven
S Marréaud
R D T Oliver
EORTC Genito-Urinary Tract Cancer Group